Veeva Systems And BioMarin Expand Long-Term Enterprise Partnership To Accelerate Therapy Development And Commercialization

Partnership to help BioMarin increase speed and efficiency

 in developing and commercializing innovative therapies

PLEASANTON, Calif., and SAN RAFAEL, Calif., Jan. 8, 2026 /PRNewswire/ -- Veeva Systems (NYSE:VEEV) and BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced a long-term enterprise agreement that builds upon their long-standing relationship.

The expanded partnership will help BioMarin increase speed, agility, operational efficiency, and optimize the healthcare professional and patient experience by further leveraging and providing strategic input into Veeva's software, data, services, and consulting products.